Back to News
Market Impact: 0.15

Which Is the Better Consumer Staples ETF: Fidelity's FSTA or iShares' IYK?

WMTCOSTPGKOPMNFLXNVDAPOWR
Consumer Demand & RetailCompany FundamentalsCapital Returns (Dividends / Buybacks)Investor Sentiment & PositioningAnalyst InsightsMarket Technicals & FlowsHealthcare & Biotech

FSTA offers a materially lower expense ratio (0.08% vs. IYK 0.38%) and higher 1-year total return (7.5% vs. 4.1%), while IYK yields slightly more (2.4% vs. 2.0%). FSTA has broader coverage (104 stocks), a 98% consumer-defensive tilt and larger AUM ($1.5B vs. $1.3B), but a slightly deeper 5-year max drawdown (-16.58% vs. -15.05%) and heavier concentration in Walmart/Costco; IYK is more concentrated (54 stocks) with ~11% healthcare exposure. Recommendation view: FSTA is preferred for lower cost and retail exposure; IYK suits investors seeking higher yield and modestly lower drawdown.

Analysis

FSTA’s heavy retail concentration around a few mega-cap anchors creates a convexity to retail-specific shocks: supply‑chain dislocations, membership churn, or an idiosyncratic earnings miss at Walmart or Costco will propagate through FSTA disproportionately and compress its effective diversification. That same concentration, however, magnifies the upside when deflationary or mid‑cycle consumption patterns favor big‑box buying power (faster inventory turns, favorable slotting fees, and private‑label margin capture), making FSTA a higher‑beta way to own “defensive” retail exposure for cyclical turnarounds. The largest macro catalysts to watch are near‑term CPI/real wage prints and shipping/commodity cost trajectories — both drive retailer margins within one quarter and can flip relative performance between FSTA and a broader staples blend in 30–90 days. Over 6–18 months, the sequencing of rate cuts (or lack thereof) and recession depth matter more: shallow slowdowns tend to favor discounters and membership models, while deeper recessions increase the value of healthcare exposure embedded in IYK. Consensus is underweight the diversification premium that healthcare adds to staples; if a growth shock or equity de‑risking event occurs, IYK’s healthcare sleeve could outperform despite FSTA’s lower fees. Conversely, the fee edge on FSTA is not a free lunch — tracking error and top‑10 stock idiosyncrasy can swamp 1–3bps of expense savings in stress periods, so the optimal trade is not a blind fee chase but a view‑based exposure to retail vs blended staples risk factors.

AllMind AI Terminal